Clinical Trial Update: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults [Phase 3]

View source ↗

Summary

Phase 3 study evaluating co-administration of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with and without Ribavirin in treatment-naive adults with hepatiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Dasabuvir (dasabuvir)
• Ombitasvir (ombitasvir)
• Paritaprevir (paritaprevir)
• Ribavirin (ribavirin)
• Ritonavir (Ritonavir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C Virus (HCV Infection Genotype 1) | Phase 3 | Status: COMPLETED | Results posted: 2016-12-12